This review examines the structural and biologic features that determine clinical activity, including target selection, linker stability, payload class, drug-to-antibody ratio, tumor penetration, biomarkers, toxicity, and resistance.
A. Philipovskiy, Scott Shurmur, Muhammad Bilal Abid· Cancers· 0 citations